APRT, adenine phosphoribosyltransferase, 353

N. diseases: 384; N. variants: 12
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Adenine phosphoribosyltransferase deficiency
1.000 GeneticVariation disease UNIPROT Identification of a single missense mutation in the adenine phosphoribosyltransferase (APRT) gene from five Icelandic patients and a British patient. 1746557 1991
Adenine phosphoribosyltransferase deficiency
1.000 GeneticVariation disease UNIPROT Missense mutation in the adenine phosphoribosyltransferase gene causing 2,8-dihydroxyadenine urolithiasis. 7915931 1994
Adenine phosphoribosyltransferase deficiency
1.000 GeneticVariation disease UNIPROT Only three mutations account for almost all defective alleles causing adenine phosphoribosyltransferase deficiency in Japanese patients. 1353080 1992
Adenine phosphoribosyltransferase deficiency
1.000 GeneticVariation disease BEFREE A case of a compound heterozygote for adenine phosphoribosyltransferase deficiency (APRT*J/APRT*Q0) leading to 2,8-dihydroxyadenine urolithiasis: review of the reported cases with 2,8-dihydroxyadenine stones in Japan. 8455250 1993
Adenine phosphoribosyltransferase deficiency
1.000 GeneticVariation disease UNIPROT A Japanese boy with adenine phosphoribosyltransferase (APRT) deficiency caused by compound heterozygosity including a novel missense mutation in APRT gene. 21635362 2011
Adenine phosphoribosyltransferase deficiency
1.000 GeneticVariation disease BEFREE We investigated the APRT gene from three patients with APRT deficiency and two novel mutations, G133D and V84M, were determined. 15571218 2004
Adenine phosphoribosyltransferase deficiency
1.000 GeneticVariation disease UNIPROT We investigated the APRT gene from three patients with APRT deficiency and two novel mutations, G133D and V84M, were determined. 15571218 2004
Adenine phosphoribosyltransferase deficiency
1.000 GeneticVariation disease UNIPROT 2,8-Dihydroxyadenine urolithiasis in a patient with considerable residual adenine phosphoribosyltransferase activity in cell extracts but with mutations in both copies of APRT. 11243733 2001
Adenine phosphoribosyltransferase deficiency
1.000 GeneticVariation disease BEFREE Results of the first patient harbouring the homozygous 254 bp deletion-8 bp insertion of the APRT gene strongly indicated that definitive diagnosis of APRT deficiency (often under or misdiagnosed) would require a combined clinical, biochemical and molecular biological evaluation. 17126311 2007
Adenine phosphoribosyltransferase deficiency
1.000 GeneticVariation disease UNIPROT Human adenine phosphoribosyltransferase deficiency. Demonstration of a single mutant allele common to the Japanese. 3343350 1988
Adenine phosphoribosyltransferase deficiency
1.000 GeneticVariation disease BEFREE Identification of a compound heterozygote for adenine phosphoribosyltransferase deficiency (APRT*J/APART*Q0) leading to 2,8-dihydroxyadenine urolithiasis. 2227934 1990
Adenine phosphoribosyltransferase deficiency
1.000 GeneticVariation disease UNIPROT Human adenine phosphoribosyltransferase. Identification of allelic mutations at the nucleotide level as a cause of complete deficiency of the enzyme. 3680503 1987
CUI: C3665382
Disease: 2,8-Dihydroxyadenine Urolithiasis
2,8-Dihydroxyadenine Urolithiasis
0.800 GeneticVariation disease BEFREE The comparative analysis shown here also provides structural information for the mechanism by which mutations in the human APRT lead to DHA-urolithiasis. 15196008 2004
CUI: C3665382
Disease: 2,8-Dihydroxyadenine Urolithiasis
2,8-Dihydroxyadenine Urolithiasis
0.800 GeneticVariation disease BEFREE 2,8-Dihydroxyadenine urolithiasis in a patient with considerable residual adenine phosphoribosyltransferase activity in cell extracts but with mutations in both copies of APRT. 11243733 2001
CUI: C3665382
Disease: 2,8-Dihydroxyadenine Urolithiasis
2,8-Dihydroxyadenine Urolithiasis
0.800 GeneticVariation disease BEFREE A mutant adenine phosphoribosyltransferase in 2,8-dihydroxyadenine urolithiasis. 3767554 1986
CUI: C3665382
Disease: 2,8-Dihydroxyadenine Urolithiasis
2,8-Dihydroxyadenine Urolithiasis
0.800 GeneticVariation disease BEFREE We report here the first evidence that 2,8-dihydroxyadenine urolithiasis developed in a boy aged 2 years with a genotype of APRT*J/APRT*Q0. 2227934 1990
CUI: C3665382
Disease: 2,8-Dihydroxyadenine Urolithiasis
2,8-Dihydroxyadenine Urolithiasis
0.800 GeneticVariation disease BEFREE Identification of two novel mutations in adenine phosphoribosyltransferase gene in patients with 2,8-dihydroxyadenine urolithiasis. 15571218 2004
CUI: C1561643
Disease: Chronic Kidney Diseases
Chronic Kidney Diseases
0.390 GeneticVariation group BEFREE Adenine phosphoribosyltransferase (APRT) deficiency, cystinuria, Dent disease, familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC), and primary hyperoxaluria (PH) are rare but important causes of severe kidney stone disease and/or chronic kidney disease in children. 23334384 2013
CUI: C1561643
Disease: Chronic Kidney Diseases
Chronic Kidney Diseases
0.390 GeneticVariation group BEFREE Adenine phosphoribosyltransferase (APRT) deficiency (OMIM #614723) is a rare autosomal recessive defect in the purine salvage pathway that causes excessive production of 2,8-dihydroxyadenine, leading to nephrolithiasis and chronic kidney disease (CKD). 30106368 2018
CUI: C0451641
Disease: Urolithiasis
Urolithiasis
0.330 GeneticVariation disease BEFREE Adenine phosphoribosyltransferase (APRT) deficiency leading to 2,8-dihydroxyadenine (DHA) urolithiasis has been considered a rare cause of urolithiasis and renal insufficiency. 3817810 1987
CUI: C0451641
Disease: Urolithiasis
Urolithiasis
0.330 GeneticVariation disease BEFREE In the present investigations, we have shown that this characteristic is common in mutant enzymes from all the four separate Japanese urolithiasis families associated with partial APRT deficiencies so far tested. 3876264 1985
CUI: C0392525
Disease: Nephrolithiasis
Nephrolithiasis
0.170 GeneticVariation disease BEFREE Adenine phosphoribosyltransferase (APRT) deficiency (OMIM #614723) is a rare autosomal recessive defect in the purine salvage pathway that causes excessive production of 2,8-dihydroxyadenine, leading to nephrolithiasis and chronic kidney disease (CKD). 30106368 2018
CUI: C0392525
Disease: Nephrolithiasis
Nephrolithiasis
0.170 GeneticVariation disease BEFREE Adenine phosphoribosyltransferase (APRT) deficiency is a rare autosomal recessive disorder of adenine metabolism that results in excessive urinary excretion of the poorly soluble 2,8-dihydroxyadenine (DHA), leading to kidney stones and chronic kidney disease. 31378568 2020
CUI: C1565489
Disease: Renal Insufficiency
Renal Insufficiency
0.110 GeneticVariation disease BEFREE Adenine phosphoribosyltransferase (APRT) deficiency leading to 2,8-dihydroxyadenine (DHA) urolithiasis has been considered a rare cause of urolithiasis and renal insufficiency. 3817810 1987
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.100 GeneticVariation group BEFREE Loss-of-function mutations of cyclic-AMP response element binding protein, binding protein (CREBBP) are prevalent in lymphoid malignancies. 28825697 2017